Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Common Stock | Options Exercise | $97.8K | +1K | +1.41% | $97.78 | 72K | Jan 3, 2022 | Direct | |
transaction | MLAB | Common Stock | Sale | -$328K | -1K | -1.39% | $327.77 | 71K | Jan 3, 2022 | Direct | F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MLAB | Non Qualified Stock Option | Exercise of in-the-money or at-the-money derivative security | $0 | -1K | -33.1% | $0.00 | 2.02K | Jan 3, 2022 | Common Stock | 1K | $97.78 | Direct | F1 |
Id | Content |
---|---|
F1 | 1/5 exercisable on each anniversary date of the 04/01/2016 grant date |
F2 | Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on June 14, 2021 |